Cargando…

Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells

Recent studies have demonstrated that the anti-diabetic drug, metformin, can exhibit direct antitumoral effects, or can indirectly decrease tumor proliferation by improving insulin sensitivity. Despite these recent advances, the underlying molecular mechanisms involved in decreasing tumor formation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Queiroz, Eveline A. I. F., Puukila, Stephanie, Eichler, Rosangela, Sampaio, Sandra C., Forsyth, Heidi L., Lees, Simon J., Barbosa, Aneli M., Dekker, Robert F. H., Fortes, Zuleica B., Khaper, Neelam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032293/ https://www.ncbi.nlm.nih.gov/pubmed/24858012 http://dx.doi.org/10.1371/journal.pone.0098207

Ejemplares similares

Hypoglycemic and Hypocholesterolemic Effects of Botryosphaeran from Botryosphaeria rhodina MAMB-05 in Diabetes-Induced and Hyperlipidemia Conditions in Rats
por: Miranda-Nantes, Carolina C. B. O., et al.
Publicado: (2011)

Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1
por: Fodor, Tamás, et al.
Publicado: (2016)

Secoisolariciresinol Diglucoside Abrogates Oxidative Stress-Induced Damage in Cardiac Iron Overload Condition
por: Puukila, Stephanie, et al.
Publicado: (2015)

Metformin inhibits estrogen‐dependent endometrial cancer cell growth by activating the AMPK–FOXO1 signal pathway
por: Zou, Jingfang, et al.
Publicado: (2016)

Chronic glucocorticoid exposure causes brown adipose tissue whitening, alters whole‐body glucose metabolism and increases tissue uncoupling protein‐1
por: Bel, Jocelyn S., et al.
Publicado: (2022)

CHIP Regulates AKT/FoxO/Bim Signaling in MCF7 and MCF10A Cells
por: Lv, Yanrong, et al.
Publicado: (2013)

Voluntary physical activity prevents insulin resistance in a tissue specific manner
por: Sarvas, Jessica L, et al.
Publicado: (2015)

Mirabegron: The most promising adipose tissue beiging agent
por: Bel, Jocelyn S., et al.
Publicado: (2021)

Metformin Protects From Rotenone–Induced Nigrostriatal Neuronal Death in Adult Mice by Activating AMPK-FOXO3 Signaling and Mitigation of Angiogenesis
por: El-Ghaiesh, Sabah H., et al.
Publicado: (2020)

Interleukin‐6 deficiency causes tissue‐specific changes in signaling pathways in response to high‐fat diet and physical activity
por: Sarvas, Jessica L., et al.
Publicado: (2014)

Metformin Targets Foxo1 to Control Glucose Homeostasis
por: Guo, Xiaoqin, et al.
Publicado: (2021)

The antiproliferative potential and mechanism of action of metformin in MCF-7 cells
por: Bekezhankyzy, Zhibek, et al.
Publicado: (2023)

Metabolic regulation by the intestinal metformin-AMPK axis
por: Zhang, Song-Yang, et al.
Publicado: (2022)

Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
por: Groenendijk, Floris H, et al.
Publicado: (2015)

Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal
por: Brynildsen, Julia K., et al.
Publicado: (2018)

The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective
por: Agius, Loranne, et al.
Publicado: (2020)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
por: Singh, Manrose, et al.
Publicado: (2022)

Metformin Attenuates ROS via FOXO3 Activation in Immune Cells
por: Hartwig, Jelka, et al.
Publicado: (2021)

Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK
por: Wang, Yu, et al.
Publicado: (2019)

Metformin regulates myoblast differentiation through an AMPK-dependent mechanism
por: Maniscalco, Eleonora, et al.
Publicado: (2023)

Sulfonated (1→6)-β-d-Glucan (Lasiodiplodan): Preparation, Characterization and Bioactive Properties
por: Calegari, Gabrielle Cristina, et al.
Publicado: (2019)

Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK‐dependent mechanisms
por: Bu, Yizhi, et al.
Publicado: (2022)

Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms
por: Chen, Suet Ching, et al.
Publicado: (2017)

Regulation of hepatic glucose production and AMPK by AICAR but not by metformin depends on drug uptake through the equilibrative nucleoside transporter 1 (ENT1)
por: Logie, Lisa, et al.
Publicado: (2018)

Fungal Exocellular (1-6)-β-d-glucan: Carboxymethylation, Characterization, and Antioxidant Activity
por: Theis, Thais Vanessa, et al.
Publicado: (2019)

Metformin enhances the chemosensitivity of hepatocarcinoma cells to cisplatin through AMPK pathway
por: Dong, Hao, et al.
Publicado: (2017)

Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK
por: Ying, Ying, et al.
Publicado: (2017)

Metformin limits osteoarthritis development and progression through activation of AMPK signalling
por: Li, Jun, et al.
Publicado: (2020)

Metformin attenuates diabetic renal injury via the AMPK-autophagy axis
por: Sun, Tingli, et al.
Publicado: (2021)

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
por: Cheng, Demin, et al.
Publicado: (2021)

Axin-Mediated Regulation of Lifespan and Muscle Health in C. elegans Requires AMPK-FOXO Signaling
por: Mallick, Avijit, et al.
Publicado: (2020)

Energy stress modulation of AMPK/FoxO3 signaling inhibits mitochondria-associated ferroptosis
por: Zhong, Sufang, et al.
Publicado: (2023)

The Effect of Different Glucose Concentrations on the Antiproliferative Activity of Metformin in MCF-7 Breast Cancer Cells
por: Nurzhan, Sholpan, et al.
Publicado: (2023)

Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo
por: Cai, Xianbin, et al.
Publicado: (2015)

Solasonine Suppresses the Proliferation of Acute Monocytic Leukemia Through the Activation of the AMPK/FOXO3A Axis
por: Zhang, Hong, et al.
Publicado: (2021)

Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway
por: Cho, Kumsun, et al.
Publicado: (2015)

Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons
por: Bayliss, Jacqueline A., et al.
Publicado: (2016)

Metformin, an AMPK Activator, Inhibits Activation of FLSs but Promotes HAPLN1 Secretion
por: Chen, Yong, et al.
Publicado: (2020)

The importance of the AMPK gamma 1 subunit in metformin suppression of liver glucose production
por: An, Hongying, et al.
Publicado: (2020)

Metformin selectively dampens the acute inflammatory response through an AMPK-dependent mechanism
por: Postler, Thomas S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rr9i41hhthiurignehrbm3bc1h